ENSG00000118520


Homo sapiens

Features
Gene ID: ENSG00000118520
  
Biological name :ARG1
  
Synonyms : ARG1 / arginase 1 / P05089
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 6
Strand: 1
Band: q23.2
Gene start: 131573144
Gene end: 131584332
  
Corresponding Affymetrix probe sets: 206177_s_at (Human Genome U133 Plus 2.0 Array)   231662_at (Human Genome U133 Plus 2.0 Array)   231663_s_at (Human Genome U133 Plus 2.0 Array)   231665_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000349446
Ensembl peptide - ENSP00000357066
Ensembl peptide - ENSP00000492623
NCBI entrez gene - 383     See in Manteia.
OMIM - 608313
RefSeq - XM_011535801
RefSeq - NM_000045
RefSeq - NM_001244438
RefSeq Peptide - NP_001231367
RefSeq Peptide - NP_000036
swissprot - P05089
Ensembl - ENSG00000118520
  
Related genetic diseases (OMIM): 207800 - Argininemia, 207800
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 arg1ENSDARG00000057429Danio rerio
 Arg1ENSMUSG00000019987Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
ARG2 / P78540 / arginase 2ENSG0000008118158
AGMAT / Q9BSE5 / agmatinaseENSG0000011677122


Protein motifs (from Interpro)
Interpro ID Name
 IPR006035  Ureohydrolase
 IPR014033  Arginase
 IPR020855  Ureohydrolase, manganese-binding site
 IPR023696  Ureohydrolase domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0000050 urea cycle TAS
 biological_processGO:0001889 liver development IEA
 biological_processGO:0001938 positive regulation of endothelial cell proliferation IEA
 biological_processGO:0002250 adaptive immune response IEA
 biological_processGO:0002376 immune system process IEA
 biological_processGO:0006525 arginine metabolic process IEA
 biological_processGO:0006527 arginine catabolic process TAS
 biological_processGO:0007565 female pregnancy IEA
 biological_processGO:0007568 aging IEA
 biological_processGO:0009611 response to wounding IEA
 biological_processGO:0009635 response to herbicide IEA
 biological_processGO:0010042 response to manganese ion IEA
 biological_processGO:0010043 response to zinc ion IEA
 biological_processGO:0010269 response to selenium ion IEA
 biological_processGO:0010963 regulation of L-arginine import IEA
 biological_processGO:0014075 response to amine IEA
 biological_processGO:0019547 arginine catabolic process to ornithine IEA
 biological_processGO:0030324 lung development IEA
 biological_processGO:0032496 response to lipopolysaccharide IEA
 biological_processGO:0032964 collagen biosynthetic process IEA
 biological_processGO:0033189 response to vitamin A IEA
 biological_processGO:0033197 response to vitamin E IEA
 biological_processGO:0042130 negative regulation of T cell proliferation IDA
 biological_processGO:0042493 response to drug IEA
 biological_processGO:0042832 defense response to protozoan IEA
 biological_processGO:0043200 response to amino acid IEA
 biological_processGO:0043312 neutrophil degranulation TAS
 biological_processGO:0043434 response to peptide hormone IEA
 biological_processGO:0045087 innate immune response IEA
 biological_processGO:0046007 negative regulation of activated T cell proliferation IEA
 biological_processGO:0046686 response to cadmium ion IEA
 biological_processGO:0048545 response to steroid hormone IEA
 biological_processGO:0048678 response to axon injury IEA
 biological_processGO:0051597 response to methylmercury IEA
 biological_processGO:0060056 mammary gland involution IEA
 biological_processGO:0060135 maternal process involved in female pregnancy IEA
 biological_processGO:0060336 negative regulation of interferon-gamma-mediated signaling pathway IMP
 biological_processGO:0070207 protein homotrimerization IEA
 biological_processGO:0070301 cellular response to hydrogen peroxide IEA
 biological_processGO:0070965 positive regulation of neutrophil mediated killing of fungus IMP
 biological_processGO:0071222 cellular response to lipopolysaccharide IEA
 biological_processGO:0071353 cellular response to interleukin-4 IEA
 biological_processGO:0071377 cellular response to glucagon stimulus IEA
 biological_processGO:0071549 cellular response to dexamethasone stimulus IEA
 biological_processGO:0071560 cellular response to transforming growth factor beta stimulus IEA
 biological_processGO:2000552 negative regulation of T-helper 2 cell cytokine production IEA
 cellular_componentGO:0005576 extracellular region TAS
 cellular_componentGO:0005615 extracellular space IDA
 cellular_componentGO:0005634 nucleus HDA
 cellular_componentGO:0005737 cytoplasm TAS
 cellular_componentGO:0005741 mitochondrial outer membrane IEA
 cellular_componentGO:0005829 cytosol TAS
 cellular_componentGO:0035578 azurophil granule lumen TAS
 cellular_componentGO:0035580 specific granule lumen TAS
 cellular_componentGO:0043005 neuron projection IEA
 cellular_componentGO:0043025 neuronal cell body IEA
 cellular_componentGO:0070062 extracellular exosome HDA
 molecular_functionGO:0004053 arginase activity TAS
 molecular_functionGO:0016787 hydrolase activity IEA
 molecular_functionGO:0016813 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines IEA
 molecular_functionGO:0030145 manganese ion binding IEA
 molecular_functionGO:0046872 metal ion binding IEA


Pathways (from Reactome)
Pathway description
Neutrophil degranulation
Urea cycle


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000708 Behavioural/Psychiatric Abnormality 
Show

 HP:0000737 Irritability 
Show

 HP:0000752 Hyperactivity 
Show

 HP:0001249 Mental retardation 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001263 Developmental retardation "A delay in the achievement of motor or mental milestones manifested prior to age 18 and generally associated with lifelong mental and/or physical impairments." [HPO:curators]
Show

 HP:0001987 Hyperammonemia 
Show

 HP:0002013 Vomiting 
Show

 HP:0002039 Anorexia 
Show

 HP:0002167 Neurological speech impairment 
Show

 HP:0002353 EEG abnormalities "Abnormality observed by electroencephalogram (EEG), which is used to record of the brain s spontaneous electrical activity from multiple electrodes placed on the scalp." [HPO:curators]
Show

 HP:0002478 Progressive spastic quadriplegia 
Show

 HP:0003218 Oroticaciduria 
Show

 HP:0004374 Hemiplegia/hemiparesis "Loss of strength in the arm, leg, and sometimes face on one side of the body. Hemiplegia refers to a severe or complete loss of strength, whereas hemiparesis refers to a relatively mild loss of strength." [HPO:curators]
Show

 HP:0008339 Diaminoaciduria 
Show

 HP:0008897 Growth retardation, progressive 
Show

 HP:0010864 Mental retardation, severe "Moderate mental retardation is defined as an intelligence quotient (IQ) in the range of 20-34." [HPO:probinson]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000118520 ARG1 / P05089 / arginase 1  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr